Ajanta Pharma Ltd share price logo

Ajanta Pharma Ltd Share Price (AJANTPHARM)

₹2638.50.68%

as on

| Source : NSE

bell
The current prices are delayed by 15 mins, login to check live prices.

Ajanta Pharma Ltd Stock Performance

as on August 22, 2025 at 4:01 PM IST

  • Day's Low

    Day's High

    ₹2,616.5
    ₹2,656.5
    downward going graph

    0.83%

    Downside

    0.68%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    ₹2,327.3
    ₹3,485
    downward going graph

    11.79%

    Downside

    32.08%

    Upside

    downward going graph
Previous Close₹2,656.50
Open₹2,650.20
Volume51.05K
Upper Circuit₹3,187.80
Lower Circuit₹2,125.20
Day's Low2,616.5
Day's High2,656.5
52 Week Low2,327.3
52 Week High3,485
1 Month Return-3.05 %
3 Month Return+ 3.23 %
1 Year Return-14.94 %
3 Year Return+ 104.8 %
5 Year Return+ 147.33 %

Ajanta Pharma Ltd Stock Fundamentals & Key Indicators

Check Ajanta Pharma Ltd market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

₹33,189.15 Cr

Return on Equity (ROE)

26.05

PE Ratio (TTM)

35.75

Return on capital employed (ROCE)

32.78

Industry PE ratio

43.37

Beta (LTM)

0.71

P/B Ratio

9.05

Dividend Yield

1.07

PEG Ratio

5.52

Quarterly Earnings Growth YOY

3.89

EPS (TTM)

73.43

Sector

Pharmaceuticals

Book Value

302.38

Technical Analysis

Ajanta Pharma Ltd Stock's Interest Amongst Investors

20%

Period Aug 23, 2025 to Jul 24, 2025. Change in 30 Days vs previous period

Search interest for Ajanta Pharma Ltd Stock has increased by 20% in the last 30 days, reflecting an upward trend in search activity.

Ajanta Pharma Ltd Stock Valuation

Track how Ajanta Pharma Ltd P/E has moved over time to understand its valuation trends.

Ajanta Pharma Ltd in the last 5 years

  • Overview

  • Trends

Lowest (17.12x)

June 6, 2018

Today (35.75x)

August 21, 2025

Industry (43.37x)

August 21, 2025

Highest (50.52x)

September 10, 2024

LowHigh

Today’s Price to Earnings Ratio: 35.75x

Ajanta Pharma Ltd Stock Recommendation

Get updated buy, sell, and hold recommendations by analysts on Ajanta Pharma Ltd.

based on 12 analysts

BUY

66.67%

Buy

16.67%

Hold

16.67%

Sell

66.67% of analysts recommend a 'BUY' rating for Ajanta Pharma Ltd. Average target price of ₹3008.33

Source: S&P Global Market Intelligence

Ajanta Pharma Ltd Share Price Target

Get share price movements and forecasts by analysts on Ajanta Pharma Ltd.

Ajanta Pharma Ltd price forecast by 12 analysts

Upside of13.24%

High

₹3293

Target

₹3008.33

Low

₹2307

Ajanta Pharma Ltd target price ₹3008.33, a slight upside of 13.24% compared to current price of ₹2638.5. According to 12 analysts rating.

Source: S&P Global Market Intelligence

Ajanta Pharma Ltd Financial Results

Get the annual and quarterly financial summary of Ajanta Pharma Ltd, including revenue, profit, loss and more.

Value in ₹ crore
DetailsQ1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26
Revenue

(in ₹ Cr)

1145 (0%)1187 (4%)1146 (3%)1170 (2%)1303 (11%)
Net Income

(in ₹ Cr)

246 (0%)216 (12%)233 (8%)225 (3%)255 (13%)
Net Profit Margin21.47% (0%)18.24% (15%)20.32% (11%)19.25% (5%)19.60% (2%)
Value in ₹ crore
DetailsFY22FY23FY24FY25
Total Assets

(in ₹ Cr)

4081 (0%)4713 (16%)4673 (1%)5052 (8%)
Total Liabilities

(in ₹ Cr)

816 (0%)1325 (62%)1106 (17%)1262 (14%)
Value in ₹ crore
DetailsFY21FY22FY23FY24FY25
Operating Cash Flow

(in ₹ Cr)

467 (0%)542 (16%)736 (36%)735 (0%)1054 (43%)

Ajanta Pharma Ltd Earnings and Dividends

View detailed summary of the earnings and dividend history of Ajanta Pharma Ltd.

  • Ajanta Pharma Ltd Earnings Results

    Ajanta Pharma Ltd’s net profit jumped 3.89% since last year same period to ₹255.34Cr in the Q1 2025-2026. On a quarterly growth basis, Ajanta Pharma Ltd has generated 13.35% jump in its net profits since last 3-months.

    Read More about Earnings Results
  • Ajanta Pharma Ltd Dividends October,2024

    In the quarter ending September 2024, Ajanta Pharma Ltd has declared dividend of ₹28.00 per share on 28 Oct 2024 - translating a dividend yield of 2.03%.

    Read More about Dividends

Indices Featuring Ajanta Pharma Ltd Stock

Check stock indices that include Ajanta Pharma Ltd.

Nifty Midcap 150

₹21,438.20

-0.18 (-38%)

BSE Mid-Cap

₹45,890.28

-0.23 (-103.54%)

BSE Healthcare

₹44,807.68

0.09 (40.48%)

Nifty MidSmallcap 400

₹19,868.60

-0.17 (-34.05%)

NIFTY PHARMA

₹22,265.00

0.39 (87.3%)

S&P BSE 250 LargeMidCap

₹10,723.81

-0.7 (-75.81%)

S&P BSE 400 MidSmallCap

₹11,994.23

-0.28 (-33.43%)

S&P BSE 150 MidCap

₹15,940.58

-0.28 (-45.56%)

Nifty LargeMidcap 250

₹16,160.70

-0.5 (-80.65%)

Nifty 500

₹22,991.30

-0.63 (-145.85%)

BSE 500

₹36,089.64

-0.66 (-239.07%)

Ajanta Pharma Ltd Stock Shareholding Pattern

View the shareholding pattern breakup of promoters, FIIs, DIIs, and retail investors in Ajanta Pharma Ltd.

InvestorsHoldings %Quarterly Trend3M change
Promoter Holdings
66.26%
0.00
Foreign Institutions
8.86%
-0.07
Mutual Funds
14.72%
-2.67
Retail Investors
7.38%
-0.13
Others
2.78%
17.77

Ajanta Pharma Ltd vs Peers

Compare market cap, revenue, PE, and other key metrics of Ajanta Pharma Ltd with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
BUY33,189.1529.47%0.529204,648
BUY12,139.11-7.93%0.524132,013
BUY60,996.213.95%0.603,48331,723
HOLD99,194.5529.9%0.614,61423,241
BUY69,349.3818.45%0.001,4146,445

Ajanta Pharma Ltd News & Key Events

Latest news and events in one place to help you make informed investing decisions in Ajanta Pharma Ltd.

  • Ajanta Pharma Shares Drop Amid Income Tax Raids - 19 Aug, 2025

    Ajanta Pharma shares fell 3% following reports of Income Tax raids at the company's premises. Investors are cautious as details remain unclear.
  • Ajanta Pharma Reports Strong Sales Growth in June 2025 - 29 Jul, 2025

    Ajanta Pharma's standalone net sales for June 2025 reached Rs 1,208.56 crore, a 12.19% increase year-over-year. Net profit also rose by 8.02%. The stock closed at Rs 2,767.10 on July 25, 2025, with notable returns over the past six and twelve months.
  • Ajanta Pharma Reports Strong Q1 Earnings Growth - 28 Jul, 2025

    Ajanta Pharma's consolidated net profit increased by 4% to ₹255 crore in Q1 2025, supported by robust revenue growth of 13.8% to ₹1,303 crore. The company also allotted 23,525 equity shares under ESOP, raising its paid-up capital.

Insights on Ajanta Pharma Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, 225.26 Cr → 255.34 Cr (in ₹), with an average increase of 11.8% per quarter

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 3 quarters, 1.17K Cr → 1.32K Cr (in ₹), with an average increase of 5.8% per quarter

  • imgNO EFFECT

    FII Holding Unchanged

    img

    Foreign Institutions holdings remained unchanged at 8.86% of holdings in Jun 2025 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Torrent Pharmaceuticals Ltd has given 138.9% return, outperforming this stock by 34.1%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Divis Laboratories Ltd has given 22.7% return, outperforming this stock by 37.7%

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 66.26% of holdings in Jun 2025 quarter

  • imgNEGATIVE IMPACT

    Retail Holding Down

    img

    Retail Investor have decreased holdings from 7.39% to 7.38% in Jun 2025 quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, AJANTPHARM stock has moved down by -1.3%

  • imgNEGATIVE IMPACT

    MF Holding Down

    img

    Mutual Funds have decreased holdings from 15.13% to 14.72% in Jun 2025 quarter

About Ajanta Pharma Ltd

Ajanta Pharma is a specialty pharmaceutical company with a wide range of products spanning across 30 countries. It works across therapeutic segments including AntiBiotic AntiMalarial AntiDiabetic Cardiology Gynecology Orthopedics Pediatric Respiratory and General Health products. Founded in 1973, it is headquartered in Mumbai India and has a mission of Serving Global Health Care Needs Worldwide. In their 47 years of operations, they have grown their operations by adding 7 state-of-the-art manufacturing facilities, 2 in India approved by the United States Food and Drug Administration (USFDA). Their Research & Development Centre in Mumbai has a team of over 750 scientists working on innovative products that are supplied to various government bodies in India, the US market and WHO approved programmes in Africa. The company also has 6 subsidiaries and 1 step-down subsidiary worldwide with investments in capex growing from Rs 997 crore to Rs 1225 crore. In addition, the company also has undertaken buybacks of 769230 equity shares in March 2019 and 735000 equity shares in November 2020. 16 new products were launched in FY2022, including 4 1st to market products in the country, 3 new products were launched with 8 ANDAs being filed and receiving 2 final and 1 tentative approval with 20 more pending approval from the USFDA.

Revenue: ₹1,302.65Cr as on June 2025 (Q1 FY26)
Net Profit: ₹255.34Cr as on June 2025 (Q1 FY26)
Listing date: 29 May, 2000
Chairperson Name: Mannalal B Agrawal
OrganisationAjanta Pharma Ltd
IndustryPharmaceuticals
CEOMannalal B Agrawal
E-voting on sharesClick here to vote

Mutual Funds that own Ajanta Pharma Ltd Stock

Check out the Mutual Funds with significant holdings in Ajanta Pharma Ltd.

FAQs

What is Ajanta Pharma Ltd share price today?

Ajanta Pharma Ltd share price today stands at ₹2638.5, Open: ₹2650.2, Previous Close: ₹2656.5, High: ₹2656.5, Low: ₹2616.5, 52 Week High: ₹3485, 52 Week Low: ₹2327.3 as on .

How to buy Ajanta Pharma Ltd shares ?

To buy Ajanta Pharma Ltd shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for AJANTPHARM or Ajanta Pharma Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Ajanta Pharma Ltd shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is today's traded volume of Ajanta Pharma Ltd?

Today's traded volume of Ajanta Pharma Ltd is 51.05K. Which means that 51.05K shares of Ajanta Pharma Ltd were bought and sold on the stock market during today's trading session.

What is Ajanta Pharma Ltd's market cap today?

Today's market capitalisation of Ajanta Pharma Ltd is ₹33,189.15 Cr. Market cap or market capitalisation is the total value of a company’s outstanding shares in the stock market, calculated by multiplying the current share price by the total number of shares issued by the company.

What is the 52 week high and 52 week low range of Ajanta Pharma Ltd?

Ajanta Pharma Ltd’s 52 week high is ₹3485 and 52 week low is ₹2327.3. The current share price of Ajanta Pharma Ltd is ₹2638.5, which is -24.29% down from its 52 week high and 13.37% up from its 52 week low.